Stock Scorecard
Stock Summary for Twist Bioscience Corp (TWST) - $30.68 as of 10/3/2025 3:31:20 PM EST
Total Score
10 out of 30
Safety Score
39 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for TWST
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for TWST
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for TWST
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for TWST
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for TWST (39 out of 100)
| Stock Price Rating (Max of 10) | 8 |
| Historical Stock Price Rating (Max of 10) | 9 |
| Stock Price Trend (Max of 10) | 1 |
| Book Value (Max of 10) | 4 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 5 |
| Analyst Strong Buy Ratings (Max of 5) | 3 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 0 |
| Trading Volume (Max of 10) | 9 |
| Price to Earnings (Max of 10) | 0 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for TWST
Financial Details for TWST
Company Overview |
|
|---|---|
| Ticker | TWST |
| Company Name | Twist Bioscience Corp |
| Country | USA |
| Description | Twist Bioscience Corporation (TWST) is a leading synthetic biology firm specializing in the development and production of synthetic DNA products for a variety of applications, including pharmaceuticals, agriculture, and industrial biotechnology. Headquartered in South San Francisco, California, the company leverages its proprietary DNA synthesis technology to deliver high-quality, scalable, and cost-effective solutions to its diverse customer base. With a strong emphasis on innovation, Twist is at the forefront of the rapidly evolving synthetic biology landscape, positioning itself as a key player in advancing genetic discovery and application across multiple sectors. |
| Sector Name | HEALTHCARE |
| Industry Name | DIAGNOSTICS & RESEARCH |
| Most Recent Quarter | 6/30/2025 |
| Next Earnings Date | 11/17/2025 |
Stock Price History |
|
| Last Day Price | 30.68 |
| Price 4 Years Ago | 77.39 |
| Last Day Price Updated | 10/3/2025 3:31:20 PM EST |
| Last Day Volume | 1,965,370 |
| Average Daily Volume | 1,491,590 |
| 52-Week High | 55.33 |
| 52-Week Low | 24.07 |
| Last Price to 52 Week Low | 27.46% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 42.17 |
| Sector PE | 41.81 |
| 5-Year Average PE | -15.71 |
| Free Cash Flow Ratio | 9.19 |
| Industry Free Cash Flow Ratio | 86.09 |
| Sector Free Cash Flow Ratio | 30.43 |
| Current Ratio Most Recent Quarter | 3.90 |
| Total Cash Per Share | 3.34 |
| Book Value Per Share Most Recent Quarter | 7.95 |
| Price to Book Ratio | 3.87 |
| Industry Price to Book Ratio | 244.77 |
| Sector Price to Book Ratio | 32.30 |
| Price to Sales Ratio Twelve Trailing Months | 5.18 |
| Industry Price to Sales Ratio Twelve Trailing Months | 4.65 |
| Sector Price to Sales Ratio Twelve Trailing Months | 20.26 |
| Analyst Buy Ratings | 6 |
| Analyst Strong Buy Ratings | 1 |
Share Statistics |
|
| Total Shares Outstanding | 60,361,000 |
| Market Capitalization | 1,851,875,480 |
| Institutional Ownership | 115.90% |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 0.00% |
| Annual Earnings Growth | -2.01% |
| Reported EPS 12 Trailing Months | -1.44 |
| Reported EPS Past Year | -1.66 |
| Reported EPS Prior Year | -3.60 |
| Net Income Twelve Trailing Months | -85,187,000 |
| Net Income Past Year | -208,726,000 |
| Net Income Prior Year | -204,618,000 |
| Quarterly Revenue Growth YOY | 17.90% |
| 5-Year Revenue Growth | 41.91% |
| Operating Margin Twelve Trailing Months | -31.40% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 201,373,000 |
| Total Cash Past Year | 226,316,000 |
| Total Cash Prior Year | 286,470,000 |
| Net Cash Position Most Recent Quarter | 201,373,000 |
| Net Cash Position Past Year | 226,316,000 |
| Long Term Debt Past Year | 0 |
| Long Term Debt Prior Year | 1,662,000 |
| Total Debt Most Recent Quarter | 0 |
| Equity to Debt Ratio Past Year | 1.00 |
| Equity to Debt Ratio Most Recent Quarter | 1.00 |
| Total Stockholder Equity Past Year | 472,689,000 |
| Total Stockholder Equity Prior Year | 623,432,000 |
| Total Stockholder Equity Most Recent Quarter | 478,198,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | -68,713,000 |
| Free Cash Flow Per Share Twelve Trailing Months | -1.14 |
| Free Cash Flow Past Year | -69,170,000 |
| Free Cash Flow Prior Year | -170,253,000 |
Options |
|
| Put/Call Ratio | 0.69 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 0.00 |
| MACD Signal | 0.00 |
| 20-Day Bollinger Lower Band | 0.00 |
| 20-Day Bollinger Middle Band | 0.00 |
| 20-Day Bollinger Upper Band | 0.00 |
| Beta | 2.39 |
| RSI | 0.00 |
| 50-Day SMA | 0.00 |
| 150-Day SMA | 0.00 |
| 200-Day SMA | 0.00 |
System |
|
| Modified | 10/4/2025 11:16:45 AM EST |